Testing effectiveness (Phase 2)UnknownNCT04614493
What this trial is testing
Innovative SonoCloud-9 Device for Blood Brain Barrier Opening in First Line Temozolomide Glioblastoma Patients.
Who this might be right for
Initial Radiological Diagnosis Eligible for Tumor ResectionInitial Radiological Diagnosis Compatible With Newly Diagnosed Glioblastoma (IDH Wild-type)Eligible for the Standard of Care Including Concurrent Temoradiation and Adjuvant Temozolomide
Assistance Publique - Hôpitaux de Paris 66